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Abstract
Background: The nature of complications and outcomes for Ventricular septal defect (VSD) repair differ between 
developed and developing countries. Understanding these differences can help optimize patient management 
according to geographical location.
Objective: The purpose of this study was to investigate the risk factors associated with in-hospital peri- and 
post-surgical complications of VSD repair in a developing country.
Design: A retrospective cohort study.
Setting: A tertiary referral center.
Participants: 117 patients under 18 years of age admitted for surgical closure of ventricular septal defect 
between July 1998 and June 2008.
Main Outcomes: Only patients with isolated VSD or VSD associated with acyanotic congenital heart disease 
were included. Outcomes were defined as in-hospital minor and major complications and mortality.
Results: Adverse complications occurred in 35.9% (42/117) and death in 3.4% (4/117) of cases. Age >12 
months (OR 0.17 13 months-5 years; 0.10 5-18 years), weight >10 kg (OR 0.24 11-20 kg; 0.13>21 kg), and absence 
of pulmonary artery hypertension (OR 0.43) were all significantly associated with a reduced rate of adverse events. 
A longer stay in intensive care unit/semi-intensive care unit (OR 11.6 5-7 days; OR 6.1 >8 days) and larger size of 
ventricular septal defect (OR 5.4 medium size; 3.9 large size) were associated with an increased risk of adverse 
events. Infection (20%) and pneumonia (10%) were the commonest complications.
Conclusions and relevance: Age under one year, weight less than ten kilograms, pulmonary artery 
hypertension, and moderate to large size ventricular septal defect are more likely to be associated with adverse 
outcomes after surgical repair of ventricular septal defect. Infection and pneumonia comprise almost one third of 
the total complications, compared to higher arrhythmic events in developed countries. Developing countries have a 
distinct spectrum of complications that may be avoidable and treatable.
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Introduction
Ventricular septal defect (VSD) is the most common congenital 
abnormality of the heart, accounting for 25% to 29% of all cases of 
congenital heart disease in Pakistan [1,2]. Spontaneous closure of 
VSDs occurs in 8.8% to 48%of children, depending on age [3-5], but 
surgical correction is required in 32% of cases, of which 91% are the 
Perimembranous VSD (PmVSD) type [6]. Although surgical mortality 
and morbidity have reduced significantly in developed countries, 
especially with the use of less invasive diagnostic procedures [7,8]; 
surgical outcomes remain poor for patients in a younger age group and 
with low weight at the time of surgery [9]. In spite of these data, age and 
weight remain controversial risk factors for adverse surgical outcome 
for children with VSD, with some studies suggesting that these factors 
are less important, particularly in developing countries [10,11]. The 
types of anatomic defects and hemodynamic factors in VSD in relation 
to operative outcome have not been studied for patients treated in 
Pakistan. Therefore the purpose of this study was to comprehensively 
evaluate the demographic, morphologic, and hemodynamic aspects 
of VSD and their associations with surgical outcome, and assess the 
spectrum of complications occurring in a developing country tertiary 
referral center.
Patients and Methods
Study population
Aga Khan University Hospital (AKUH), Karachi, Pakistan, 
is a tertiary referral center for pediatric surgery. We performed a 
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retrospective cohort study of 117 consecutive pediatric patients 
admitted for surgical closure of a VSD. Patients aged from birth to 18 
years of age were identified in the ten-year period between July 1998 
and June 2008. Approval for the study was granted from the ethics 
committee and institutional review board of AKUH.
Eligibility
All patients diagnosed with isolated VSD or VSDs associated with 
acyanotic heart disease-like atrial septal defect (ASD), patent ductus 
arteriosus (PDA), mitral stenosis (MS), mitral regurgitation (MR), 
pulmonary stenosis (PS), aortic stenosis (AS), aortic regurgitation (AR) 
or coarctation of the aorta (COA), and who subsequently underwent 
surgery, were included in the study. Patients with VSDs associated with 
complex cardiac lesions such as double-outlet ventricle, tetralogy of 
fallot, transposition of the great arteries, pulmonary atresia, tricuspid 
atresia, truncus arteriosus or single ventricle were excluded from the 
study.
Data collection procedures
The patient records of AKUH were queried in order to collect data 
on patients meeting the stated criteria. For each patient the number 
of VSD, type of VSD, size of VSD, associated diagnosis with VSD, and 
outcomes were collected.
Diagnostic criteria and variables
All patients were diagnosed using transthoracic echocardiography 
performed by a pediatric cardiologist. For this study, VSD was classified 
as PmVSD, muscular, inlet, and doubly committed subarterial/
supracristal VSD. If a patient had more than one type of VSD, then 
only the larger-sized VSD was considered in the analysis. The size of the 
VSDs were categorized as small, moderate, and large if the VSD was less 
than 1/3, between 1/3 and 2/3, or more than 2/3 of the aortic root size, 
respectively. If a patient had multiple VSDs, then the sizes were added. 
The transthoracic echocardiography report was available in 115 out of 
117 patients, and the size of VSD could not be categorized according 
to aortic root size in 22 out of 117 patients. Cardiac catheterization 
is done in 43 patients. No of patients with available information for 
demographic and morphologic data are mentioned in Table 3.
A pediatric cardiologist and cardiac surgeon preformed the 
preoperative clinical evaluation and laboratory tests. The pediatric 
cardiologist assessed pulmonary artery hypertension (PAH) using a 
combination of echocardiography and cardiac catheterization, which 
was also performed to investigate potential reversibility of PAH and to 
rule out complex cardiac morphology in selected cases. If infection was 
identified, patients received antibiotics and surgery was delayed for four 
weeks.
Main outcome measures
Outcomes were determined in the time between surgery and 
discharge from hospital. Minor and major complications and death 
were considered as a single category of “adverse outcome”. In-hospital 
complications included significant residual lesion, ventricular 
dysfunction, pericardial effusion, pericarditis, pericardial tamponade, 
right bundle branch block, transient heart block, transient rhythm 
abnormalities, insertion of permanent pacemaker for complete heart 
block, pleural effusion, pneumonia, lung collapse, pneumothorax, need 
for redo-surgery, neurological complications (such as seizures), renal 
insufficiency, infection, re-intubation, cardiopulmonary resuscitation, 
and gastrointestinal bleeding. A favorable outcome was defined as a 
patient discharged with no complications as defined above. Mortality 
was defined as peri-operative or post-operative death before discharge 
from hospital.
Statistical analysis
The dependent variable was binary: adverse event or no adverse 
event. The following independent variables were used to identify risk 
factors for adverse events. Within each independent variable group, 
one subgroup was selected as the reference to calculate odds ratio (OR) 
for adverse events for the other subgroups relative to the reference 
group: age <12 months for “age”, <5 kg for “weight”, yes for “PAH”, 
1-1.5 for “Qp:Qs”, 0.5-1.5 for “pulmonary vascular resistance (PVR)”, 
0-4 days for “duration of stay in Intensive care unit/semi-intensive care 
unit(ICU/SICU)”, perimembranous for “VSD type”, single for “number 
of VSDs”, small for “size of VSD”, and yes or ASD for “associated defect”. 
Data for each group of variables are presented as OR comparing each 
subgroup to its respective reference subgroup; ORs were determined 
using the 2-way contingency table chi-square test. Bias was reduced by 
considering all patients within the study period, which also determined 
the study size. Missing data were excluded from the analysis. Values of 
p<0.05 were considered significant. Data were analyzed using SPSS for 
Windows (IBM Inc.) version 16.0.
Results
A total of 117 patients underwent open-heart surgery for the repair 
of VSD. The baseline clinical characteristics of the patients are shown 
in Table 1.
The distribution of demographics, types of morphologic defect 
and hemodynamic factors are shown in Table 2. PmVSD was the 
most common type of defect, identified in 65% (75/115) of patients, 
followed by supracristal VSD (22%; 25/115), muscular VSD (9%; 
10/115), and inlet-type VSD (3%; 4/115). One patient was diagnosed 
with a Gerbodes-type VSD. A single VSD was found in 94% of patients 
(108/115). The VSD was small in 24.2% (23/95), medium sized in 33.7% 
(32/95), and large in 42.1% (40/95) of patients.  VSDs were associated 
with other congenital cardiac defects in 65% (76/117) of cases. The 
associated defects were PS (9%; 11/117), ASD (11%; 13/117), PDA 
Variable n
Age (year) 5 yr ± 4 (3 to 17 yr)
Age category
Less than one year 25 (21%)
One to five years 52 (45%)
five to 18 years 40 (34%)
Gender (M:F) 1.3:1.0
Mean BSA(cm2) 0.6
Weight (Kg) 15.5 ± 10.93 (3.1 to 60)
Weight category 14 (12%)
Less than 5 kg
6 to 10 kg 21 (18%)
11 to 20 kg 55 (47%)
More than 21 kg 13 (11%)
Genetic syndrome 15/117 (13%)
Down’s syndrome 10/117 (8.5%)
Qp:Qs ratio 2.3  ± 1.3 (1.0 to 7.0)
Pulmonary vascular resistance index 
(Woods unit/m2)
3.4 ± 2.6 (0.5 to 11.3)
PA band before surgery 19/112 (17%)
Stay in ICU/SICU (days) 4 ± 4 (1 to 24)
Duration of intubation (Hours) 20 ± s34 (1 to 211)
Table 1: Clinical characteristics of the patients in this study.
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(13%; 15/117), MR (17%; 20/117), and MS in one patient, COA in 
two patients, AS in two patients, AR (26%; 30/117), and aortic valve 
prolapsed (AVP) (30%; 35/117). Cardiac catheterization was performed 
in 37% (43/117) of cases, and 50% (58/117) of patients had PAH. 16% 
(19/117) of patients had undergone pulmonary artery banding (PA 
band) prior to VSD repair.
Overall, 35.9% (42/117) patients had adverse complications and 
death occurred in 3.4% (4/117) of cases. 18% (21/117) of patients 
had more than one complication (Table 2). Infections (including 
pneumonia) were the most common complication, occurring in 30% 
of patients. Transient rhythm abnormalities were the next frequent 
complication, occurring in 13% patients.
Age >12 months (OR 0.17 13 months-5 years; 0.10 5-18 years), 
weight >10 kg (OR 0.24 11-20 kg; 0.13 >21 kg), and absence of PAH 
(OR 0.43) were all significantly associated with a reduced rate of 
adverse events (Table 3). A longer stay in ICU/SICU (OR 11.6 5-7 days; 
6.1>8 days) and larger size of VSD (OR 5.4 medium size; 3.9 large size) 
were significantly associated with an increased rate of adverse events 
(Table 3). The inlet type of VSD (OR 15.8) and very high PVR (OR 
21.7) demonstrated a trend towards association with adverse events, 
although not quite reaching statistical significance.
Patients with VSDs associated with ASD or PDA had an adverse 
outcome in 54% and 53% of cases, respectively, followed by AR, MR, 
and aortic valve prolapse in 33%, 30%, and 29% of cases, although these 
associations were not significant due to small sample sizes.
Discussion
We have shown that patients under one year old, under ten 
kilograms, with PAH and moderate to large sized VSDs were more likely 
to have an adverse outcome after surgery for repair of VSD. Infection 
and pneumonia comprised almost one third of total complications. The 
inlet type of VSD had the worst outcomes.
In terms of overall outcomes, our in-hospital mortality of 3.4% 
was higher than recent published mortality rates for VSD repair in 
developed countries.  Mortality has been reduced to between 0.5% 
and 1.7% [7-9] in Western healthcare systems, which has fallen from 
8.2% only two decades age [8], and much lower than the mortality rates 
shown for the same procedure in the Indian subcontinent [10-13].
Adverse outcome n % 
Ventricular dysfunction 10 9
Pericardial effusion 6 5
Transient heart block 2 2
Transient rhythm abnormality 14 13
Permanent pace maker 1 1
Pleural effusion required 
chest tube
8 7
Pneumonia 12 10
Lung collapse 5 4
Need redo surgery 2 2
Seizures 7 6
Infections 22 20
Failure to extubate on 
planned day
5 4
CPR 9 8
GIT bleeding 1 1
Intraoperative complications 7 6
Clot in mediastinum 1 1
Total 112
Table 2: Details of the peri- and post-operative complications observed in this 
study.
Variable n Adverse 
event (n)
Rate of 
adverse 
event (%)
Odds ratio 
(95% CI; p-value)
Age
<12 months 25 19 76 1
13 months-5 years 52 18 35 0.17 (0.06-0.49; 0.0012)
5-18 years 40 10 25 0.10 (0.03-0.34; 0.0001)
Weight
<5 kg 14 11 79 1
6-10 kg 21 10 48 0.24 (0.05-1.15; p=0.08)
11-20 kg 55 18 33 0.13 (0.03-0.53; p=0.005)
>21 kg 13 8 62 0.12 (0.03-0.53; p=0.0053)
PAH
Yes 58 30 52 1
No 54 17 31 0.43 (0.20-0.93; p=0.03)
Qp:Qs
1-1.5 12 5 42 1
1.6-2.0 10 2 20 0.35 (0.05-2.4; p=0.28)
2.1-4.0 15 6 40 0.93 (0.19-4.4; p=0.93)
4.1-6.0 2 1 50 1.4 (0.07-28.1; p=0.83)
>6.1 1 1 100 4 (0.13-120.7; p=0.41)
PVR
0.5-1.5 7 1 14 1
1.6-3.0 6 1 17 1.2 (0.05-24.5; p=0.91)
3.1-4.5 9 3 33 3 (0.24-37.7; p=0.85)
4.6-6.0 3 1 33 3 (0.24-37.7; p=0.85)
>6.0 2 2 100 21.7 (0.64-730.1; p=0.09)
Duration of stay in ICU/SICU
0-4 days 81 20 23 1
5-7 days 24 19 79 11.6 (3.83-35.1; p<0.0001)
>8 days 12 8 67 6.1 (1.7-22.4; p=0.0065)
VSD Type
Perimembranous 75 27 36 1
Muscular 10 5 33 1.7 (0.47-6.70; p=0.39)
Inlet 4 4 100 15.8 (0.82-306.0; p=0.07)
Supracristal VSD 25 9 36 1 (0.39-2.57; p=1.0)
Gerbodes 1 0 0 0.58 (0.02-14.9; p=0.74)
Number of VSDs
Single 108 44 41 1
Multiple 7 3 43 1.1 (0.23-5.11; p=0.11)
Size of VSD
Small 23 4 17 1
Medium 32 17 53 5.4 (1.5-19.4; p=0.01)
Large 40 18 45 3.9 (1.11-13.5; p=0.03)
Associated defects
Yes 76 28 37 1
No 41 19 46 1.5 (0.68-3.1; p=0.32)
PS 11 5 45 1
ASD 13 7 54 1.4 (0.27-7.0; p=0.68)
PDA 15 8 53 1.37 (0.39-6.6; p=0.69)
MR 20 6 30 0.51 (0.11-2.4; p=0.39)
MS 1 0 0 0.39 (0.01-11.8; p=0.59)
COA 2 1 50 1.2 (0.06-24.5; p=0.12)
AS 2 0 0 0.24 (0.009-6.0; p=0.38)
AR 30 10 33 0.60 (0.15-5.6; p=0.48)
Prolapse of 
coronary cusp
35 10 29 0.48 (0.12-1.94; p=0.30)
Table 3: Association of demographics, morphology, and hemodynamic factors with 
outcome.
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Between 1976 and 1996, perioperative morbidity reduced 
significantly from 29% to 15% in children who underwent large VSD 
repairs; however, changes in post-operative morbidity have remained 
static (approximately 40%; 8). This is comparable to the postoperative 
mortality seen in this study, but different in that cardiac dysrhythmia 
is the most common complication in developed countries [8], while 
infection and pneumonia were most common in our study. Anderson 
et al. identified transient or complete heart block, re-operation, and 
pleural effusion as the main complications [9], while another study 
from the Indian subcontinent also showed infection and pneumonia 
to be the most common complication (17%) in the developing country 
setting, slightly less than our rate of 31%. These data suggest that the 
nature of post-operative complications is different in developing 
countries, and may be avoidable and easily treatable.
In our study, other complications were transient heart block (2%), 
need for permanent pacemaker (1%), and re-do surgery (2%). This 
compares with 3.5% for transient heart block, 2.1% for permanent 
pacemaker, and 4.9% for re-do surgery in developed countries [9]. The 
need for a chest tube for pleural effusion in 7% of patients and seizures 
in 6% of patients compares to 3.5% and 1.7% in developed countries, 
respectively [9]. Another study reported a reoperation rate of 2.8% after 
surgical closure of an isolated single VSD, and none of these patients 
had post-operative heart block, rhythm abnormality, or a neurologic 
event [7].
Restrictive VSD is not usually referred for percutaneous or surgical 
closure due to the usual natural history of spontaneous closure or 
reduction in size. Miyake et al. studied spontaneous closure of VSD 
in infants under three month of age, and found spontaneous closure 
occurred in72% of cases without congestive heart failure (CHF), but in 
only 19% of infants with CHF [5]. Backer et al. evaluated outcomes of 
surgical repair for restrictive VSD in a low risk population with a Qp:Qs 
ration of less than 2, no PAH, and no symptoms of congestive cardiac 
failure. They reported no mortality and no complications such as heart 
block, redo surgery, or wound infection [14] in this low risk population.
In our study, complications of VSD repair were higher in patients 
with moderate and large VSDs. We did not evaluate confounding risk 
factors for adverse outcome according to different sizes of VSD. Since 
we followed standard indications for referring patients for surgery, 
we assumed that the indication for surgery in restrictive or small to 
moderately sized VSDs would be either high Qp:Qs ratio, high PVR, 
AVP with regurgitation, or deteriorating clinical condition despite 
medical therapy.
We compared our data with the risks and benefits shown for the 
operative results of restrictive VSD from Backer et al, and natural 
spontaneous closure of VSD without CHF [5,14]. Our data allow us to 
conclude that if we repair restrictive or moderately-sized VSDs before 
patients develop a high Qp:Qs ratio, higher PVR, or clinical symptoms, 
we can reduce the rate of post-operative complications.
PmVSDs were observed in 65% of patients, followed by supracristal 
VSD in 22% of cases. Associated AR and AVP were present in 26% 
and 30% of patients, respectively, and one third of patients with AR 
and AVP suffered an adverse outcome. VSD is known to be associated 
with AVP in 8.6% of cases and AR in 6.4% of cases [4]. Eroglu et al. 
found that none of the VSDs with AVP close spontaneously [4], and 
therefore these lesions require surgical intervention. Spontaneous 
closure of PmVSD without CHF is 74%, while for supracristal VSD 
only 23%, with the remaining VSDs either being small or not requiring 
surgery [5]. Backer et al. found AR and AVP in 18% and 45% of cases, 
respectively, in a low risk population who underwent VSD repair, with 
no adverse outcomes [14]. In another study, AR and AVP were found 
in 72% and 44% or patients with supracristal VSD undergoing surgical 
repair, respectively; this study also showed that the early closure of 
the supracristal VSD reduces the progression of AR [15]. These data 
suggest that early surgery before the development of AR or AVP not 
only reduces the chance of aortic valve replacement, but also reduces 
post-operative complications.
A study from India demonstrated that operative weight was not 
associated with the length of hospital stay, but that younger age and 
preoperative pneumonia required longer post-operative care [10]. In 
one study from Pakistan, operations in children under five and younger 
age were associated with adverse outcomes [12]. Another study from 
a developing country hospital reported no association between age 
and post-operative morbidity, but did suggest that this group requires 
longer post-operative care [11]. In contrast, Anderson et al determined 
that infants under six month of age, and each kilogram decrease in 
weight increased composite risk of surgery 1.8 fold [9]. In our study, age 
less than one year and weight less than ten kilograms were significantly 
associated with higher peri- and post-surgical complications. Anderson 
et al. also found that age over six months and higher weights were 
associated with reduced incidence of heart block and post-operative 
hemorrhage, respectively [9].
More than half of patients had PAH, which was significantly 
associated with adverse outcome. Several studies have shown the 
association between PAH and higher mortality and morbidity in 
patients undergoing VSD repair [12,16]. Surgical repair of small to 
moderately size shunts without PAH were the most frequent indication 
for surgical repair in the current era and is associated with significantly 
lower mortality and morbidity [8].
VSD was associated with ASD and PDA in 10 and 12% of cases 
respectively, and more than half of these cases had an adverse outcome, 
although these relationships were not statistically significant due to 
small subgroup sizes. Other studies have also identified ASD as an 
important risk factor for surgical outcome of VSD [17].
Most of the surgical morbidity in our study was due to infection 
and pneumonia, which is related to patients’ immune status and 
preoperative health. This study helps doctors to counsel families of 
high-risk patients about likely post-operative complications. Surgical or 
percutaneous repair of moderately sized VSD, regardless of symptoms 
and PAH, should be emphasized as a risk and re-evaluated. These data 
help doctors understand the need for follow up for medical therapy, 
compliance with medication in developing countries, SBE prophylaxis, 
reducing loss to follow up, the role of PAH, and factors to help reduce 
hospital stays and complications.
Limitations
There are several limitations in this study. First, this is a retrospective 
study that depended on the written documentation of several doctors, 
and therefore there were some missing data that might be difficult to 
evaluate. Second, over the ten year of period covered in this analysis, 
three different surgeons performed the surgery, with a cardiac surgeon 
specialized in pediatric cardiac surgery only starting in 2007. Third, 
this study did not differentiate between the high risk and low risk 
populations in different sizes and types of VSD repair, and therefore 
the question of which complications contribute to high risk moderately 
size VSD population remains unanswered. However, overall this study 
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provides a comprehensive overview of the problem of risk factors and 
outcome in VSD, allowing more focused evaluation in future studies.
Conclusion
Patients aged less than one year, weight under 10 kilograms, PAH, 
and moderate to large size VSDs are more likely to develop adverse 
outcomes after surgical repair. Infection and pneumonia comprise 
almost one third of the total complications in this population treated 
in a developing country.
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